Compare
Bio-Rad Laboratories vs Thermo Fisher Scientific (BIO vs TMO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Bio-Rad Laboratories (BIO) returned +23.1% and Thermo Fisher Scientific (TMO) +22.4%; so far this year the figures are +25.9% and +19.9%.
Thermo Fisher Scientific is the larger company by market value, about 25.0 times the size of Bio-Rad Laboratories.
On trailing earnings, BIO trades at 10.1 times and TMO at 36.6 times.
Revenue grew +1.4% at BIO and +8.3% at TMO over the last year.
BIO pays no dividend. TMO yields 0.26%.
Data as of the latest close. Not investment advice.
Relative performance
| BIO | TMO | |
|---|---|---|
| Price | $381.57 | $694.76 |
| 1-day | +3.41% | +2.63% |
| YTD | +25.93% | +19.90% |
| 1 year | +23.08% | +22.39% |
| 3 years | +37.50% | +57.50% |
| Market cap | $10.3B | $257.4B |
| P/E | 10.1 | 36.6 |
| P/S | 3.97 | 5.44 |
| P/B | 1.35 | 4.70 |
| Revenue growth | +1.40% | +8.30% |
| EPS growth | — | +9.50% |
| Gross margin % | 51.3 | 25.2 |
| Net margin % | 39.5 | 14.9 |
| ROE % | 13.5 | 12.9 |
| Debt / equity | 0.11 | 0.79 |
| FCF yield % | 3.2 | 3.0 |
| Dividend yield % | — | 0.26 |
| Beta | 0.75 | 0.67 |
| RSI (14) | 56.1 | 54.7 |
| Technical rating |